2015 Forty Under 40: Tristan Coram
Tristan Coram, 34, research scientist for Dow AgroSciences, works to boost global crop production.
Health Care & Life Sciences
Articles
2015 Forty Under 40: Adlai Chester
Adlai Chester, 34, chief financial officer of Mainstreet, juggles finances for more than $1 billion in post-acute health care properties.
2015 Forty Under 40: Dr. Gaurav Arora
Dr. Gaurav Arora, 39, is chief medical officer for Indiana University Health Saxony Hospital in Fishers.
IU Health to cut 96 workers in Martinsville
In a cost-cutting move, Indiana University Health plans to lay off nearly 100 workers as Morgan Hospital stops admitting overnight patients April 1.
Novartis expects price war with Lilly over psoriasis drugs
Novartis AG is racing to establish itself in the market for new treatments for psoriasis ahead of competing drugs by Amgen Inc. and Eli Lilly and Co. in the United States.
Anthem results top expectations, as firm projects growth in ’15
The Indianapolis-based health insurer hiked the quarterly dividend it pays shareholders nearly 43 percent after reporting fourth-quarter results.
Democrats, hospital group cheer Healthy Indiana Plan ruling
The top Democrat in the Indiana Senate is applauding the federal approval of Gov. Mike Pence's proposal for expansion of the Healthy Indiana Plan.
UPDATE: Healthy Indiana Plan 2.0 gets federal approval
Federal officials have approved Indiana Gov. Mike Pence’s plan to provide health insurance to lower-income Hoosiers, despite provisions that require some participants to pay part of the premium.
Health VC dollars tripled in Indiana
Indiana’s health care companies attracted $103.8 million in investments last year, the highest total since attracting 2007. However, all but $3 million of last year’s investments came during the first six months of the year and Indiana continued to lag other Midwest states.
The Billion Dollar Decision
When the U.S. Supreme Court hands down its ruling on Obamacare’s tax credits, it could zap nearly $1 billion from Hoosiers’ finances. In fact, Hoosiers buyers on Obamacare’s exchanges have more to lose, as a percentage of their incomes, than the residents of all states other than Alaska and Mississippi.
Meth bills mandating cold-pill prescriptions face tough road
Bills aiming to reduce Indiana’s methamphetamine problem by requiring prescriptions for some cold medicines probably won’t be considered in House or Senate committees this session, key lawmakers said.
IU Health on course to spare Methodist, close University
All signs point to University Hospital’s being shuttered as Indiana University Health goes from three downtown hospitals to two.
Bills filed that would allow medical marijuana in Indiana
Two Democratic lawmakers have filed bills that would allow the use of medical marijuana in Indiana, although neither measure is likely to advance in the Republican-controlled Legislature.
CEO Roundup: We’re not your father’s health care company anymore
The CEOs of Anthem, Lilly, Zimmer and Hill-Rom tried to woo investors at the J.P. Morgan Healthcare conference by stressing how they’re broadening business beyond plain-old insurance, pharmaceuticals, implants and hospital beds.
We’re at tipping point of health care becoming a real marketplace
Nearly half of all Hoosier workers covered by employer health plans are now enrolled in high-deductible, consumer-directed health plans, according to a new survey. That means the state is about to pass the point of no return on transforming health care into a real marketplace.
Lilly sees insurers pushing harder for discounts
Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.’s diabetes business chief says.
UPDATE: Lilly says it couldn’t have made tainted Cialis
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
Obamacare’s effects on Lilly: Modest pain, no gain
Since Obamcare was expected to boost insurance coverage nationally by 32 million people, drugmakers like Eli Lilly and Co. stood to benefit. But it’s not working out that way. At least not for Lilly.
UPDATE: Lilly forecasts earnings below analyst expectations
The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.
CVS to close local nutrition center with 124 workers
A division of CVS Pharmacy Inc. said it would consolidate work done at the facility to locations in Littleton, Colorado, and Jackson, Tennessee.